伴侣动物来源碳青霉烯非敏感铜绿假单胞菌的潜在人类健康风险
该研究分析了2024年日本伴侣动物(犬99株、猫98株)的197株铜绿假单胞菌临床分离株,评估其对人类临床抗菌药物的耐药性。结果显示环丙沙星耐药率20.3%、哌拉西林10.7%,多重耐药占5.6%;碳青霉烯非敏感株占17.8%,其中77.1%的序列型已知可感染人类,并首次在日本伴侣动物中发现高风险克隆ST233和ST298。
要点
- 伴侣动物铜绿假单胞菌对环丙沙星耐药率20.3%、哌拉西林10.7%,多重耐药占5.6%。
- 碳青霉烯非敏感株占17.8%,其中77.1%的序列型已知在人类中出现。
- 首次在日本伴侣动物中检出人类高风险克隆ST233和ST298(占8.6%)。
核心结论
- 伴侣动物来源的耐药铜绿假单胞菌存在跨物种传播风险,需在One Health框架下持续监测。
研究设计与样本
- 研究纳入2024年日本伴侣动物(犬99株、猫98株)共197株铜绿假单胞菌临床分离株。
- 对分离株进行人类临床抗菌药物敏感性试验,并对碳青霉烯非敏感株开展多位点序列分型和耐药基因、毒力因子检测。
主要发现
- 环丙沙星耐药率20.3%、哌拉西林耐药率10.7%,多重耐药菌占5.6%。
- 碳青霉烯耐药率:亚胺培南6.1%、美罗培南1.0%;碳青霉烯非敏感株占17.8%,但对头孢吡肟、环丙沙星或阿米卡星仍敏感。
- 27种序列型中20种(占碳青霉烯非敏感株的77.1%)为人类已知序列型,包括首次在日本伴侣动物中报道的高风险克隆ST233和ST298(占8.6%)。
- 碳青霉烯非敏感株携带外排泵相关基因突变和多种毒力因子,其中一株与人类分离株遗传关系密切,提示可能的种间传播。
临床怎么用
- 对伴侣动物来源铜绿假单胞菌应关注碳青霉烯非敏感株,并参考环丙沙星、哌拉西林等耐药率选择经验性用药。
- 发现碳青霉烯非敏感株时,建议开展分子分型以识别ST233、ST298等高风险克隆。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The close bond between companion animals and humans may accelerate the spread of antimicrobial-resistant bacteria. Pseudomonas aeruginosa, an opportunistic pathogen in both, poses a public health threat due to antimicrobial resistance (AMR) and diverse virulence factors. However, One Health-based comparison remains limited. This study investigated the current AMR status and molecular characteristics of P. aeruginosa in companion animals in Japan to assess potential human health risks. METHODS: We examined 197 P. aeruginosa clinical isolates from companion animals [dogs (n = 99) and cats (n = 98)] across Japan in 2024. Antimicrobial susceptibility to human clinical antibiotics was evaluated. In carbapenem-non-susceptible isolates, multilocus sequence typing and detection of resistance genes and virulence factors were performed. RESULTS: Ciprofloxacin (20.3%) and piperacillin (10.7%) showed the highest resistance rates, with 5.6% of isolates being multidrug-resistant. Carbapenem resistance rates were 6.1% for imipenem and 1.0% for meropenem. Thirty-five isolates (17.8%) exhibited carbapenem non-susceptibility but remained susceptible to cefepime, ciprofloxacin, or amikacin. Of 27 identified sequence types, 20 (77.1% of carbapenem-non-susceptible isolates) were known in humans, including two high-risk clones (ST233 and ST298; 8.6%) reported for the first time in Japanese companion animals. These isolates carried mutations in efflux pump-related genes and multiple virulence factors. One showed close genetic relatedness to a human isolate, suggesting possible interspecies transmission. CONCLUSIONS: Our findings highlight the potential cross-species transmission risk of antimicrobial-resistant P. aeruginosa. Identification of shared high-risk clones with multiple virulence factors emphasizes the need for continuous vigilance and actions within the One Health framework.
引用
- Toyting-Hiraishi J, Sato T, Tohyama M, et al. Potential human health risk of carbapenem-non-susceptible Pseudomonas aeruginosa from companion animals. J Antimicrob Chemother. 2025. PMID: 40973953. doi:10.1093/jac/dkaf338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。